BlackRock Inc. - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 45 filers reported holding LIANBIO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of LIANBIO
ValueSharesWeighting
Q3 2023$916,630
-59.6%
615,188
-38.3%
0.00%
Q2 2023$2,271,662
+13.3%
996,343
-2.6%
0.00%
Q1 2023$2,005,289
+19.5%
1,023,1070.0%0.00%
Q4 2022$1,677,895
-18.0%
1,023,1070.0%0.00%
Q3 2022$2,046,000
-8.2%
1,023,107
-0.9%
0.00%
Q2 2022$2,229,000
-34.2%
1,032,083
+87.7%
0.00%
Q4 2021$3,388,000550,0000.00%
Other shareholders
LIANBIO shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,282,084$4,472,8856.12%
Perceptive Advisors 57,558,451$112,814,5633.33%
SCHF (GPE), LLC 937,500$1,8383.24%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,303,573$6,475,0030.65%
Cormorant Asset Management, LP 4,250,000$8,3300.55%
Affinity Asset Advisors, LLC 650,000$1,267,5000.42%
22NW, LP 141,223$276,7970.17%
MYDA Advisors LLC 120,000$235,2000.09%
Logos Global Management LP 280,000$548,8000.08%
TANG CAPITAL MANAGEMENT LLC 209,600$410,8160.06%
View complete list of LIANBIO shareholders